At PROSCA there are several sessions covering new data, but this year two presentations really stand out.
New data from ASCO 2017, June 2-6, Chicago
Brand new data presented at the ASCO congress in the US, will be presented for the first time in Europe at PROSCA 2017. Rumour has it that this new data will change the way we look at prostate cancer.
St. Gallen Consensus 2017, March 9-11, St. Gallen
Silke Gillessen, co-founder of the Advanced Prostate Cancer Consensus Conference (APCCC) will be present at PROSCA to discuss the highlights from the 2017 consensus meeting.
Some more highlights: Getug, Stampede, Chaarted, Fizazi, Hormone-sensitive (metastatic) PCa, Oligometastatic PCa, (Early) docetaxel, Androgen-deprivation therapy / ADT, Abiraterone